Trefoil Peptides in Lung Diseases
NCT00839735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2021-02-17
Summary
The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucus hypersecretion.
Conditions
Sponsors & Collaborators
-
Bispebjerg Hospital
lead OTHER
Principal Investigators
-
Thomas K Lund, MD PhD · Respiratory and Allergy Research Unit
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2010-05-31
- Completion
- 2010-05-31
Countries
- Denmark
Study Locations
More Related Trials
-
Innate Immune Response in COPD
NCT02637219 ·Status: COMPLETED
-
Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases
NCT02807025 ·Status: UNKNOWN
-
Sputum and Plasma Levels of Nociceptin and Substance P in Patients With Asthma, COPD and Chronic Cough
NCT00173225 ·Status: UNKNOWN
-
Microaspiration in Pulmonary Fibrosis
NCT01150591 ·Status: COMPLETED
-
Correlation of FeNO, Blood Eosinophils, Bronchoalveolar Lavage Findings and Bronchial Epithelium Histopathology in Patients With Chronic Obstructive Pulmonary Disease and Asthma
NCT03845257 ·Status: TERMINATED
-
Characterizing Asthma Sputum Elasticity in the UCSF Severe Asthma Research Program
NCT02103348 ·Status: COMPLETED
-
Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific
NCT03151395 ·Status: COMPLETED ·Phase: NA
-
Novel Inflammatory Markers in Different Phenotypes of Severe Asthma
NCT04888910 ·Status: UNKNOWN
-
A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations
NCT01337661 ·Status: COMPLETED
-
Immunopathologic Profiles and Blood Biomarkers in Patients With IPF
NCT04187079 ·Status: COMPLETED
-
Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders
NCT00846573 ·Status: TERMINATED ·Phase: NA
-
Mucin Concentration in Sputum From COPD Patients During a Pulmonary Exacerbation
NCT01848093 ·Status: WITHDRAWN
-
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 1.
NCT01224938 ·Status: COMPLETED
-
Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography
NCT00001759 ·Status: COMPLETED
-
Prospective Study on the Evaluation, Patient Reported Outcomes and Effectiveness of Treatment for Chronic Cough
NCT04758351 ·Status: COMPLETED
-
Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls
NCT03125174 ·Status: COMPLETED
-
Sputum Cytology in Screening Heavy Smokers For Lung Cancer
NCT00103363 ·Status: COMPLETED ·Phase: PHASE2
-
Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction
NCT00871637 ·Status: COMPLETED
-
Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00159341 ·Status: COMPLETED ·Phase: PHASE1
-
Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
NCT04722835 ·Status: UNKNOWN
-
Effects of Smoking on Bronchial Epithelium
NCT00849433 ·Status: COMPLETED
-
Respiratory Pathogens of Patients With Asthma and COPD Exacerbations
NCT02866357 ·Status: COMPLETED
-
Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum
NCT04761393 ·Status: RECRUITING
-
Protocol TARC-ABPA
NCT01710930 ·Status: COMPLETED ·Phase: NA
-
Biomarkers for Predicting the Response to Inhaled Corticosteroid in Patients With Chronic Cough.
NCT05888350 ·Status: COMPLETED ·Phase: NA